Cytosorbents Corp (CTSO): Cost of Revenue
$10.57M
Year ended 2025-12-31
$10.57M
Trailing 12 months to 2026-06-30
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.57M | -1.3% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $10.71M | n/c | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $9.13M | n/c | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $13.96M | +26.3% | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | $11.05M | 0.0% | 2024-03-15, From 2021-01-01 |
| 2020-12-31 | $11.05M | +50.1% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $7.36M | -1.7% | 2022-03-10, From 2019-01-01 |
| 2018-12-31 | $7.49M | +35.7% | 2021-03-09, From 2018-01-01 |
| 2017-12-31 | $5.52M | +39.6% | 2020-03-05, From 2017-01-01 |
| 2016-12-31 | $3.95M | +78.7% | 2019-03-07, From 2016-01-01 |
| 2015-12-31 | $2.21M | +3.7% | 2018-03-08, From 2015-01-01 |
| 2014-12-31 | $2.13M | +11.6% | 2017-03-03, From 2014-01-01 |
| 2013-12-31 | $1.91M | +498.7% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $319.3K | n/m | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $11.8K | n/a | 2013-04-03, From 2011-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | 2025-12-31 | $10.57M | -1.3% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $14.28M | +16.4% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $38.22M | +12.2% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $16.52M | -1.4% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $14.60M | -14.1% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $190.0K | -6.9% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $15.52M | +26.1% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $22.94M | +88.1% |
| Premier Air Charter Holdings Inc. (PREM) | 2025-12-31 | $28.49M | +55.2% |
Compare CTSO, CLPT, RVP, UTMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗